Login/Sign Up
MRP ₹63984
(Inclusive of all Taxes)
₹9597.6 Cashback (15%)
Dacoplice 45mg Tablet is an anti-cancer medicine used to treat non-small cell lung cancer (NSCLC). It consists of Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of an enzyme (tyrosine kinase) that causes the multiplication of cancerous cells; this prevents the abnormal growth of cancer cells and thus reduces the spread of cancer to other parts of the body.
Provide Delivery Location
About Dacoplice 45mg Tablet
Dacoplice 45mg Tablet is an anti-cancer medicine used in the treatment of non-small cell lung cancer (NSCLC). It is a common form of lung cancer in which abnormal cells grow in the lung tissues. Dacoplice 45mg Tablet is used as a first-line therapy in the treatment of metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations.
Dacoplice 45mg Tablet consists of Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of an enzyme (tyrosine kinase) that causes the multiplication of cancerous cells. This prevents the abnormal growth of cancer cells and thus reduces the further spread to other parts of the body.
Dacoplice 45mg Tablet may cause certain side effects such as diarrhea, rash, nausea, vomiting, dry skin, mouth sores, nail inflammation, ache, cough, abdominal pain, hair loss, decreased appetite, decreased weight loss, and itching. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Dacoplice 45mg Tablet should be taken as advised by your doctor. Do not take more than the recommended dose. Your doctor will decide the dose of Dacoplice 45mg Tablet based on the severity of your condition.
Avoid taking Dacoplice 45mg Tablet if you are allergic to it or any other components of it. Before taking Dacoplice 45mg Tablet , inform your doctor if you have/had liver or kidney disease and lung disease other than lung cancer. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy and breastfeeding. Elderly people are more sensitive to medicine, so the dose may have to be adjusted according to their condition.
Uses of Dacoplice 45mg Tablet
Dacoplice 45mg Tablet is used in the treatment of Non-small cell lung cancer (NSCLC). The detailed use of Dacoplice 45mg Tablet is as follows:
Have a query?
Directions for Use
Medicinal Benefits
Dacoplice 45mg Tablet contains Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. In this way, Dacoplice 45mg Tablet stops the body's production, spread and growth of cancerous cells.
How Dacoplice 45mg Tablet Works
Storage
What if I have taken an overdose of Dacoplice 45mg Tablet
Drug Warnings
To treat your condition effectually, continue taking Dacoplice 45mg Tablet for the period that your doctor has prescribed. Avoid taking Dacoplice 45mg Tablet if you are allergic to it or any other components present in it. Caution should be exercised if you have/had liver or kidney disease, eye problems, lung disease other than lung cancer, severe cough, and breathing difficulty. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Effective birth control pills should be used for at least 17 days after the last dose of the medicine. Dacoplice 45mg Tablet may cause severe diarrhea, severe skin conditions, and Interstitial lung disease in some patients. Hence, inform your doctor about your complete medication and medical history before taking Dacoplice 45mg Tablet . Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. Avoid driving and operating machines, as this medicine may cause visual disturbances. This medicine is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
It is unknown whether alcohol may interact with Dacoplice 45mg Tablet . However, as a precautionary measure, it is advisable not to take or limit alcohol. Consult your doctor for more information.
Pregnancy
Unsafe
Dacoplice 45mg Tablet is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Dacoplice 45mg Tablet . You should not become pregnant while you are taking Dacoplice 45mg Tablet and for at least 17 days after your last dose.
Breast Feeding
Unsafe
It is not known whether Dacoplice 45mg Tablet is present in human milk. However, you should not breastfeed while taking this medicine and, for 17 days after your last dose.
Driving
Unsafe
Dacoplice 45mg Tablet may cause blurred vision as a side effect. Hence, try to avoid driving, operating machinery, or engaging in any activity that needs clear vision until you are able to see clearly while you are on treatment with Dacoplice 45mg Tablet .
Liver
Caution
If you have mild to moderate liver problems, inform your doctor before taking Dacoplice 45mg Tablet . The dose of this medicine has to be adjusted in case you have severe liver disease.
Kidney
Caution
Inform your doctor before receiving Dacoplice 45mg Tablet if you have a history of kidney diseases. No dose adjustments are required in mild to moderate renal impairment.
Children
Unsafe
Dacoplice 45mg Tablet is not recommended for children as the safety and effectiveness were not established.
Heart
Please consult your doctor before receiving Dacoplice 45mg Tablet if you have pre-existing heart problems. Your doctor will prescribe Dacoplice 45mg Tablet if the benefits outweigh the risks.
Geriatrics
Consult your doctor
Please consult a doctor before administering Dacoplice 45mg Tablet to geriatric patients. Your doctor will prescribe Dacoplice 45mg Tablet if the benefits outweigh the risks.
Dacoplice 45mg Tablet is used to treat Non-small cell lung cancer (NSCLC).
Dacoplice 45mg Tablet contains Dacominitib, which works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells.
The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer, followed by coughing.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd